Skip to main navigation
Skip to content
  • Partner Portal Login
  • News & Events
    • Press Releases
    • Latest News
    • Events
  • Investors
MaxCyte Logo
  • Products
  • Services
  • Our Approach
    • Partnership
    • Collaboration
    • Scientific Technical Support
    • Regulatory & Quality Support
  • Applications
  • Learning Hub
    • Featured Science
    • Resource Library
    • Scientific Publications
    • Webinars & Presentations
    • On-Demand Seminars
    • What cells can I use?
  • About Us
    • Our History
    • Our Team
    • Board of Directors
    • Join our Team
  • Join Our Team
  • News & Events
    • Press Releases
    • Latest News
    • Events
  • Investors
  • Contact Us
    • Ask the ExPERT
    • Request a Demo
    • Request a Quote
    • Technical Support
Menu
Mobile logo
  • Products
    • Electroporation Systems
  • Services
  • Our Approach
    • Partnership
    • Collaboration
    • Scientific Technical Support
    • Regulatory & Quality Support
  • Applications
  • Learning Hub
    • Featured Science
    • Resource Library
    • Scientific Publications
    • Webinars & Presentations
    • On-Demand Seminars
    • What cells can I use?
  • About Us
    • Our History
    • Our Team
    • Board of Directors
    • Join our Team
  • Join Our Team
  • News & Events
    • Press Releases
    • Latest News
    • Events
  • Investors
  • Contact Us
    • Ask the ExPERT
    • Request a Demo
    • Request a Quote
    • Technical Support

SEC Filing Details

Site - Investor Relations

  • Investors
  • News and Events
    News Releases Events Documents and Presentations
  • Stock Info
    Stock Quote & Chart Historical Price Lookup Analyst Coverage
  • Governance
    Documents & Charters Senior Management Board of Directors Committee Composition
  • ESG
  • Financials
    SEC Filings
  • IR Resources
    Email Alerts FAQs Contact IR

Document Details

Form
8-K
Filing Date
Aug 11, 2025
Document Date
Aug 11, 2025
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
MaxCyte Inc
Issuer
MAXCYTE, INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - EX-101.LAB
EX-101.PRE - EX-101.PRE
XML - XBRL INSTANCE DOCUMENT
  • RSS Feeds
  • Email Alerts
  • Contact IR
  • Search
MaxCyte Logo

Platforms

Platforms
  • Electroporation Systems
  • Processing Assemblies
  • Reagents & Accessories

Who We Serve

Who We Serve
  • Cell & Gene Therapy
  • Bioprocessing
  • Discovery & Translational Research

Our Approach

Our Approach
  • Our Technology
  • Technical & Regulatory Support
  • Partnerships
  • Collaboration

About Us

About Us
  • About MaxCyte
  • Our History
  • Our Team
  • Board of Directors
  • Join our Team
Investors
Distributors

Follow Us

Ask the ExPERT

Request a Quote

Technical Support

© 2026 MaxCyte. All Rights Reserved.

  • Quality Systems
  • Privacy Policy
  • Terms and Conditions
  • Legal Disclaimer

Electroporation Systems

ATX_01

ATx

From small to medium static Electroporation.

STX_01

STx

Transfect up to 20 billion cells with scalable static or Flow Electroporation®.

GTx

GTx

Transfect up to 20 billion cells with our clinically validated and cGMP compliant Flow Electroporation®.

VLX

VLx

For gram scale protein production.

Our Electroporation Technology

Consumables

Processing Assemblies
Processing Assemblies

Achieve the desired scale and throughput with a range of consumable devices.

Accessories & Reagents
Reagents & Supporting Products

Complement your workflow with our flexible electroporation buffer formats and accessories.

Gene Editing Risk Assessment

About SeQure DX™

Screening Assays

Guide Profiler™

Guide Select™

Nomination Assays

ONE-seq

DEUX-seq™

GUIDE-seq™

Confirmation Assays

Amplicon-seq™

SAFER Detection™

Applications

Cell Therapy

Discover scalable engineering to enable safe and potent cell therapies.

Gene Editing

Navigate the complexities of genome engineering with highly efficient delivery.

Protein & Antibody Production

Accelerate biotherapeutic development with transient expression for gram-scale protein production.

Cell Based Assays

Produce assay-ready cells faster with scalable electroporation.

Viral Vector

Transfect adherent or suspension cells to produce a variety of viral vectors.

Vaccine Development

Innovate vaccine research with our adaptable platform for production of recombinant proteins, virus-like particles.

Industries

Cell & Gene Therapy

Partnering with developers to accelerate development and scale cell therapy programs toward clinical success.

Discovery & Translational Research

Accelerating breakthrough discoveries with high-efficiency, reproducible electroporation across cell types.

Bioprocessing

Enabling efficient, reproducible transfection in virtually any cell type for high-yield transient expression and rapid cell line development.